Glenmark Pharmaceuticals Limited has informed the Exchange regarding Appointment of Mr. Anurag Mantri as Executive Director and Global Chief Financial Officer of the company w.e.f. May 27, 2025.

Management Changes View source PDF Explain this filing

GLENMARK · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.3%Reaction day

₹1421.90

prior close

₹1370.00

announcement price

After-mkt

timing

Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)+0.6%-2.9% vs market

Pharmaceuticals peers, median of 148sector+0.4%-2.7% vs sector

On the reaction day the stock moved 2.9 pts less than Nifty Midcap 150 and 2.7 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+3.4

10m

+3.1

15m

+3.4

30m

+3.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.3+0.6-2.9+0.4-2.7

Next day

-2.8+0.8-3.6+0.4-3.2

-3.0+0.8-3.8+0.5-3.5

-0.8+1.4-2.2+1.1-1.9

+2.7+1.2+1.5+0.6+2.2

+5.4+1.8+3.7-0.1+5.5

+6.8+2.2+4.6+0.1+6.7

15d

+18.2+3.4+14.7+1.5+16.7

+21.5+4.2+17.3-1.2+22.7

+50.3+2.1+48.1+0.6+49.7

+37.1+1.2+36.0-1.8+38.9

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 148Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Glenmark Pharmaceuticals has appointed Mr. Anurag Mantri as the Executive Director and Global Chief Financial Officer (CFO) of the company. The appointment is effective from May 27, 2025. As Global CFO, he will oversee the financial strategy and operations of the company. The company has informed the stock exchange about this key managerial appointment. No further details on his previous role or compensation were provided in this filing.

Likely market impact

A new CFO appointment is a key leadership change that can influence the company's financial strategy, capital allocation decisions, and investor confidence. Shareholders should watch for any subsequent disclosures regarding Mantri's background and prior experience.